Opus Genetics, Inc. SEC filings IRD
Opus Genetics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 17, 2005. Its latest annual report, Form ARS, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 5, 2026 | Nov 3, 2026 |
| 144 | Notice of proposed sale | Nov 3, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 27, 2026 | — |
| 4 | Insider transaction | Oct 27, 2026 | Oct 23, 2026 |
| 4 | Insider transaction | Oct 27, 2026 | Oct 23, 2026 |
| 4 | Insider transaction | Oct 27, 2026 | Oct 23, 2026 |
| 4 | Insider transaction | Oct 27, 2026 | Oct 23, 2026 |
| 144 | Notice of proposed sale | Oct 23, 2026 | — |
| 144 | Notice of proposed sale | Oct 23, 2026 | — |
| 144 | Notice of proposed sale | Oct 23, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Oct 21, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2026 | Oct 14, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Sep 11, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 11, 2026 | Sep 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 9, 2026 | Sep 9, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 3, 2026 |
| 144 | Notice of proposed sale | Sep 3, 2026 | — |
| EFFECT | Filing | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| CORRESP | Letter to the SEC | Aug 13, 2026 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2026 | — |
| S-3 | Shelf registration | Aug 7, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 23, 2026 |
| 144 | Notice of proposed sale | Jul 23, 2026 | — |
| 144 | Notice of proposed sale | Jul 23, 2026 | — |
| 144 | Notice of proposed sale | Jul 23, 2026 | — |
| 144 | Notice of proposed sale | Jul 23, 2026 | — |
| 424B2 | Prospectus | Jun 17, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 16, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 16, 2026 | Jun 16, 2026 |
| EFFECT | Filing | Jun 15, 2026 | — |
| CORRESP | Letter to the SEC | Jun 11, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2026 | — |
| S-3 | Shelf registration | Jun 5, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 20, 2026 | — |
| 4 | Insider transaction | May 20, 2026 | May 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| S-8 | Employee stock plan registration | May 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 13, 2026 | — |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 23, 2026 |
| 8-K |
Current report
New debt
|
Apr 24, 2026 | Apr 21, 2026 |
| 144 | Notice of proposed sale | Apr 23, 2026 | — |
| 144 | Notice of proposed sale | Apr 23, 2026 | — |
| 144 | Notice of proposed sale | Apr 23, 2026 | — |
| 144 | Notice of proposed sale | Apr 23, 2026 | — |
| 144 | Notice of proposed sale | Apr 23, 2026 | — |
| EFFECT | Filing | Apr 22, 2026 | — |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Apr 22, 2026 | Apr 20, 2026 |
| CORRESP | Letter to the SEC | Apr 21, 2026 | — |
| S-3/A | Filing | Apr 21, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Apr 7, 2026 | Apr 1, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Apr 7, 2026 | Apr 2, 2026 |
| ARS | Annual report to shareholders | Mar 23, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Mar 23, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| UPLOAD | Letter from the SEC | Mar 17, 2026 | — |
| 144 | Notice of proposed sale | Mar 16, 2026 | — |
| S-3 | Shelf registration | Mar 13, 2026 | — |
| PRE 14A | Preliminary proxy statement | Mar 12, 2026 | Apr 20, 2026 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Feb 19, 2026 | Feb 13, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| S-8 | Employee stock plan registration | Jan 22, 2026 | — |
| 4 | Insider transaction | Jan 21, 2026 | Jan 18, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 8, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Dec 31, 2025 | Dec 29, 2025 |
| 8-K |
Current report
Other events
|
Dec 19, 2025 | Dec 17, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 11, 2025 | — |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 6, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| FWP | Free writing prospectus | Nov 6, 2025 | — |
| 424B5 | Prospectus supplement | Nov 6, 2025 | — |
| 4/A | Filing | Nov 5, 2025 | Nov 1, 2025 |
| 4 | Insider transaction | Nov 4, 2025 | Nov 1, 2025 |
| 4 | Insider transaction | Oct 24, 2025 | Oct 22, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 30, 2025 | Sep 30, 2025 |
| S-8 | Employee stock plan registration | Sep 26, 2025 | — |
| 4 | Insider transaction | Sep 11, 2025 | Sep 2, 2025 |
| 3 | Initial insider ownership | Sep 11, 2025 | Sep 2, 2025 |
| S-8 | Employee stock plan registration | Sep 10, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 2, 2025 | Aug 29, 2025 |
| 4 | Insider transaction | Aug 27, 2025 | Aug 25, 2025 |
| 4 | Insider transaction | Aug 27, 2025 | Aug 25, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Aug 25, 2025 | Aug 25, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 11, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 23, 2025 | Jul 22, 2025 |
| 424B5 | Prospectus supplement | Jun 26, 2025 | — |
| 8-K |
Current report
Other events
|
Jun 26, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 25, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 23, 2025 | Jun 23, 2025 |
| 8-K |
Current report
Material agreement
|
Jun 20, 2025 | Jun 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 15, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 5, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 6, 2025 | — |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 1, 2025 | Apr 30, 2025 |
| DEFA14A | Additional proxy material | Apr 14, 2025 | — |
| PX14A6G | Filing | Apr 11, 2025 | — |
| DEFA14A | Additional proxy material | Apr 11, 2025 | — |
| EFFECT | Filing | Apr 10, 2025 | — |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| DFAN14A | Filing | Apr 9, 2025 | — |
| CORRESP | Letter to the SEC | Apr 9, 2025 | — |
| CORRESP | Letter to the SEC | Apr 8, 2025 | — |
| S-3/A | Filing | Apr 8, 2025 | — |
| CORRESP | Letter to the SEC | Apr 7, 2025 | — |
| DEFA14A | Additional proxy material | Apr 7, 2025 | — |
| 8-K |
Current report
Agreement ended
|
Apr 4, 2025 | Apr 2, 2025 |
| 424B5 | Prospectus supplement | Apr 4, 2025 | — |
| PRRN14A | Filing | Apr 4, 2025 | — |
| DEFC14A | Preliminary proxy statement | Apr 2, 2025 | — |
| DFAN14A | Filing | Apr 2, 2025 | — |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 31, 2025 | — |
| PRER14A | Preliminary proxy statement | Mar 31, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| UPLOAD | Letter from the SEC | Mar 28, 2025 | — |
| DFAN14A | Filing | Mar 28, 2025 | — |
| 4 | Insider transaction | Mar 26, 2025 | Mar 24, 2025 |
| 4 | Insider transaction | Mar 26, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Mar 24, 2025 | Mar 21, 2025 |
| 424B5 | Prospectus supplement | Mar 24, 2025 | — |
| DFAN14A | Filing | Mar 21, 2025 | — |
| PRER14A | Preliminary proxy statement | Mar 21, 2025 | — |
| PREC14A | Filing | Mar 21, 2025 | — |
| FWP | Free writing prospectus | Mar 21, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 20, 2025 | Mar 20, 2025 |
| FWP | Free writing prospectus | Mar 20, 2025 | — |
| 424B5 | Prospectus supplement | Mar 20, 2025 | — |
| PREC14A | Preliminary proxy statement | Mar 20, 2025 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Mar 20, 2025 | Mar 19, 2025 |
| 4 | Insider transaction | Mar 17, 2025 | Mar 13, 2025 |
| 4 | Insider transaction | Mar 17, 2025 | Mar 13, 2025 |
| 4 | Insider transaction | Mar 17, 2025 | Mar 13, 2025 |
| 4 | Insider transaction | Mar 17, 2025 | Mar 13, 2025 |
| 4 | Insider transaction | Mar 17, 2025 | Mar 13, 2025 |
| 4 | Insider transaction | Mar 17, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Other events
|
Mar 4, 2025 | Mar 4, 2025 |
| UPLOAD | Letter from the SEC | Feb 26, 2025 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IRD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Durham, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1228627
- Former names
- Ocuphire Pharma, Inc. (until Oct 22, 2024); REXAHN PHARMACEUTICALS, INC. (until Nov 9, 2020); CORPORATE ROAD SHOW DOT COM INC (until Apr 29, 2005); FERRARO FRANK (until Apr 29, 2003)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.